The 5-Second Trick For "3
Other scientific trials in individuals with non-Hodgkin's lymphoma [24] and sufferers with State-of-the-art malignancy [fourteen] have demonstrated also that zosuquidar did not significantly affect the pharmacokinetics of doxorubicin and experienced reasonable outcomes on the pharmacokinetics of vincristine. These scientific trials authorized that